Skip to main content

Advertisement

Log in

Influence of Ovarian Endometrioma on Expression of Steroid Receptor RNA Activator, Estrogen Receptors, Vascular Endothelial Growth Factor, and Thrombospondin 1 in the Surrounding Ovarian Tissues

  • Original Article
  • Published:
Reproductive Sciences Aims and scope Submit manuscript

Abstract

This study investigates the influence of ovarian endometrioma on expression of steroid receptor RNA activator (SRA), estrogen receptors (ERs), vascular endothelial growth factor (VEGF), and thrombospondin 1 (TSP-1) in the surrounding ovarian tissues. Taken from the women with ovarian endometrioma and mature teratoma during laparoscopy, the biopsies were analyzed by real-time polymerase chain reaction and Western blot. Our results indicated that ovarian tissues surrounding endometrioma had lower SRA and ER-α levels but higher SRA protein (SRAP) and ER-β levels than ovarian endometrioma. With lower VEGF levels and higher TSP-1 levels, the surrounding ovarian tissues showed higher expression levels of SRA, SRAP, ER-α, and ER-β in the ovarian endometrioma group when compared to the controls. These data showed that ovarian endometrioma increases SRA, ERs, and TSP-1 but decreases VEGF levels in the surrounding ovarian tissues, suggesting that abnormal expression of these molecules may affect biological behaviors of ovarian endometrioma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Daniell JF, Kurtz BR, Gurley LD. Laser laparoscopic management of large endometriomas. Fertil Steril. 1991;55(4):692–695.

    Article  CAS  PubMed  Google Scholar 

  2. Donnez J, Nisolle M, Gillet N, Smets M, Bassil S, Casanas-Roux F. Large ovarian endometriomas. Hum Reprod. 1996;11(3):641–646.

    Article  CAS  PubMed  Google Scholar 

  3. Sutton CJ, Ewen SP, Jacobs SA, Whitelaw NL. Laser laparoscopic surgery in the treatment of ovarian endometriomas. J Am Assoc Gynecol Laparosc. 1997;4(3):319–323.

    Article  CAS  PubMed  Google Scholar 

  4. Muzii L, Bellati F, Bianchi A, et al. Laparoscopic stripping of endometriomas: a randomized trial on different surgical techniques. Part II: Pathological results. Hum Reprod. 2005;20(7):1987–1992.

    Article  PubMed  Google Scholar 

  5. Evers JL, Dunselman GA, Land JA, Bouckaert PX. Management of recurrent endometriosis. In: Couinho E, Spinola P, DeMoura LH, eds. Progress in the Management of Endometriosis. London, UK: Partheon, 1995:291–297.

    Google Scholar 

  6. Garry R. The effectiveness of laparoscopic excision of endometriosis. Curr Opin Obstet Gynecol. 2004;16(4):299–303.

    Article  PubMed  Google Scholar 

  7. Laschke MW, Elitzsch A, Vollmar B, Vajkoczy P, Menger MD. Combined inhibition of vascular endothelial growth factor (VEGF), fibroblast growth factor and platelet-derived growth factor, but not inhibition of VEGF alone, effectively suppresses angiogenesis and vessel maturation in endometriotic lesions. Hum Reprod. 2006;21(1):262–268.

    Article  CAS  PubMed  Google Scholar 

  8. Laschke MW, Menger MD. In vitro and in vivo approaches to study angiogenesis in the pathophysiology and therapy of endometriosis. Hum Reprod Update. 2007;13(4):331–342.

    Article  CAS  PubMed  Google Scholar 

  9. Tan XJ, Lang JH, Liu DY, Shen K, Leng JH, Zhu L. Expression of vascular endothelial growth factor and thrombospondin-l mRNA in patients with endometriosis. Fertil Steril. 2002;78(1):148–153.

    Article  PubMed  Google Scholar 

  10. Gilabert-Estellés J, Ramón LA, EspañaF, et al. Expression of angiogenic factors in endometriosis: its relation to fibrinolytic and metalloproteinase (MMP) systems. Hum Reprod. 2007;22(8):2120–2127.

    Article  PubMed  CAS  Google Scholar 

  11. Ramón LA, Braza-Boïls A, Gilabert-Estellés J, et al. microRNAs expression in endometriosis and their relation to angiogenic factors. Hum Reprod. 2011;26(5): 1082–1090.

    Article  PubMed  CAS  Google Scholar 

  12. Lanz RB, McKenna NJ, Onate SA, et al. A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex. Cell. 1999;97(1):17–27.

    Article  CAS  PubMed  Google Scholar 

  13. Leygue E, Dotzlaw H, Watson PH, Murphy LC. Expression of the steroid receptor RNA activator in human breast tumors. Cancer Res. 1999;59(17):4190–4193.

    CAS  PubMed  Google Scholar 

  14. Lanz RB, Chua SS, Barron N, Söder BM, DeMayo F, O’Malley BW. Steroid receptor RNA activator stimulates proliferation as well as apoptosis in vivo. Mol Cell Biol. 2003;23(10):7163–7176.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Cooper C, Guo J, Yan Y, et al. Increasing the relative expression of endogenous non-coding Steroid Receptor RNA Activator (SRA) in human breast cancer cells using modified oligonucleotides. Nucleic Acids Res. 2009;37(13):4518–4531.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Agoulnik IU, Weigel NL. Coactivator selective regulation of androgen receptor activity. Steroids. 2009;74(8):669–674.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Hube F, Guo J, Chooniedass-Kothari S, et al. Alternative splicing of the first intron of the steroid receptor RNA activator (SRA) participates in the generation of coding and noncoding RNA isoforms in breast cancer cell lines. DNA Cell Biol. 2006;25(7):418–428.

    Article  CAS  PubMed  Google Scholar 

  18. Kawashima H, Takano H, Sugita S, Takahara Y, Sugimura K, Nakatani T. A novel steroid receptor co-activator protein (SRAP) as an alternative form of steroid receptor RNA-activator gene: expression in prostate cancer cells and enhancement of androgen receptor activity. Biochem J. 2003;369(pt 1):163–171.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. KurisuT, TanakaT, Ishii J, etal. Expression and function of human steroid receptor RNA activator in prostate cancer cells: role of endogenous hSRA protein in androgen receptor-mediated transcription. Prostate Cancer Prostatic Dis. 2006;9(2):173–178.

    Article  CAS  PubMed  Google Scholar 

  20. Chooniedass-Kothari S, Vincett D, Yan Y, et al. The protein encoded by the functional steroid receptor RNA activator is a new modulator of ER alpha transcriptional activity. FEBS Lett. 2010; 584(6): 1174–1180.

    Article  CAS  PubMed  Google Scholar 

  21. O’Malley BW, McKenna NJ. Coactivators and corepressors: what’s in a name? Mol Endocrinol. 2008;22(10):2213–2214.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  22. Bulun SE. Endometriosis. N Engl J Med. 2009;360(3):268–279.

    Article  CAS  PubMed  Google Scholar 

  23. Hyder SM, Nawaz Z, Chiappetta C, Stancel GM. Identification of functional estrogen response elements in the gene coding for the potent angiogenic factor vascular endothelial growth factor. Cancer Res. 2000;60(12):3183–3190.

    CAS  PubMed  Google Scholar 

  24. Mueller MD, Vigne JL, Minchenko A, Lebovic DI, Leitman DC, Taylor RN. Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors alpha and beta. Proc Natl Acad Sci USA. 2000;97(20): 10972–10977.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Attar E, Bulun SE. Aromatase and other steroidogenic genes in endometriosis: translational aspects. Hum Reprod Updat. 2006; 12(1):49–56.

    Article  CAS  Google Scholar 

  26. American Society for Reproductive Medicine. Revised American Society for Reproductive Medicine classification of endometriosis 1996. Fertil Steril. 1997;67(5):817–821.

    Article  Google Scholar 

  27. Schmid-Braz AT, Cavalli LR, Cornélio DA, et al. Comprehensive cytogenetic evaluation of a mature ovarian teratoma case. Cancer Genet Cytogenet. 2002;132(2):165–168.

    Article  CAS  PubMed  Google Scholar 

  28. Noyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. Fertil Steril. 1950;1:3–5.

    Article  Google Scholar 

  29. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C (T)) method. Methods. 2001;25(4):402–408.

    CAS  PubMed  Google Scholar 

  30. Emberley E, Huang GJ, Hamedani MK, et al. Identification of new human coding steroid receptor RNA activator isoforms. Biochem Biophys Res Commun. 2003;301(2):509–15.

    Article  CAS  PubMed  Google Scholar 

  31. Chooniedass-Kothari S, Emberley E, Hamedani MK, et al. The steroid receptor RNA activator is the first functional RNA encoding a protein. FEBS Lett. 2004;566(1–3):43–47.

    Article  CAS  PubMed  Google Scholar 

  32. Takehara M, Ueda M, Yamashita Y, Terai Y, Hung YC, Ueki M. Vascular endothelial growth factor A and C gene expression in endometriosis. Hum Pathol. 2004;35(11): 1369–1375.

    Article  CAS  PubMed  Google Scholar 

  33. Nisolle M, Donnez J. Peritoneal endometriosis, ovarian endometriosis and adenomyotic nodules of the rectovaginal septum are three different entities. Fert Steril. 1997;68(4):585–596.

    Article  CAS  Google Scholar 

  34. Borth N, Massier J, Franke C, Sachse K, Saluz HP, Hänel F. Chlamydial protease CT441 interacts with SRAP1 co-activator of estrogen receptor alpha and partially alleviates its co-activation activity. J Steroid Biochem Mol Biol. 2010;119(1–2):89–95.

    Article  CAS  PubMed  Google Scholar 

  35. Masuda H, Kalka C, Takahashi T, et al. Estrogen-mediated endothelial progenitor cell biology and kinetics for physiological postnatal vasculogenesis. Circ Res. 2007;101(6):598–606.

    Article  CAS  PubMed  Google Scholar 

  36. Masuda H, Matsuzaki Y, Hiratsu E, et al. Stem cell-like properties of the endometrial side population: implication in endometrial regeneration. PLoS One. 2010;5(4):e10387.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  37. Hegele-Hartung C, Siebel P, Peters O, et al. Impact of isotypeselective estrogen receptor agonists on ovarian function. Proc Natl Acad Sci USA. 2004;101(14):5129–5134.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Gargett CE, Schwab KE, Zillwood RM, Nguyen HPT, Wu D. Isolation and culture of epithelial progenitors and mesenchymal stem cells from human endometrium. Biol Reprod. 2009;80(6): 1136–1145.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Chan RWS, Ng EHY, Yeung WSB. Identification of cells with colony-forming activity, self-renewal capacity, and multipotency in ovarian endometriosis. Am J Pathol. 2011;178(6): 2832–2844.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Nilbert M, Pejovic T, Mandahl N, Iosif S, Willen H, Mitelman F. Monoclonal origin of endometriotic cysts. Lnt J Gynecol Cancer. 1995;5(1):61–63.

    Article  PubMed  Google Scholar 

  41. Nabeshima H, Murakami T, Yoshinaga K, Sato K, Terada Y, Okamura K. Analysis of the clonality of ectopic glands in peritoneal endometriosis using laser microdissection. Fertil Steril. 2003;80(5):1144–1150.

    Article  PubMed  Google Scholar 

  42. Jiang X, Hitchcock A, Bryan EJ, et al. Microsatellite analysis of endometriosis reveals loss of heterozygosity at candidate ovarian tumor suppressor gene loci. Cancer Res. 1996;56(15):3534–3539.

    CAS  PubMed  Google Scholar 

  43. Jimbo H, Hitomi Y, Yoshikawa H, et al. Evidence for monoclonal expansion of epithelial cells in ovarian endometrial cysts. Am J Pathol. 1997;150(4):1173–1178.

    CAS  PubMed  PubMed Central  Google Scholar 

  44. Jimbo H, Hitomi Y, Yoshikawa H, et al. Clonality analysis of bilateral ovarian endometrial cysts. Fertil Steril. 1999;72(6): 1142–1143.

    Article  CAS  PubMed  Google Scholar 

  45. Mayr D, Amann G, Siefert C, Diebold J, Anderegg B. Does endometriosis really have premalignant potential? A clonal analysis of laser-microdissected tissue. FASEB J. 2003;17(6):693–695.

    Article  CAS  PubMed  Google Scholar 

  46. Tamura M, Fukaya T, Murakami T, Uehara S, Yajima A. Analysis of clonality in human endometriotic cysts based on evaluation of X chromosome inactivation in archival formalin-fixed, paraffin-embedded tissue. Lab Invest. 1998;78(2):213–218.

    CAS  PubMed  Google Scholar 

  47. Wu Y, Basir Z, Kajdacsy-Balla A, et al. Resolution of clonal origins for endometriotic lesions using laser capture microdissection and the human androgen receptor (HUMARA) assay. Fertil Steril. 2003;79(suppl 1):710–717.

    Article  PubMed  Google Scholar 

  48. Cheong Y, Tay P, Luk F, Gan HC, Li TC, Cooke I. Laparoscopic surgery for endometriosis: how often do we need to re-operate? J Obstet Gynaecol. 2008;28(1):82–85.

    Article  CAS  PubMed  Google Scholar 

  49. Liu H, Lang J. Is abnormal eutopic endometrium the cause of endometriosis? The role of eutopic endometrium in pathogenesis of endometriosis. Med Sci Monit. 2011;17(4):RA92-RA99.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Lucidi RS, Witz CA, Chrisco M, Binkley PA, Shain SA, Schenken RS. A novel in vitro model of the early endometriotic lesion demonstrates that attachment of endometrial cells to mesothelial cells is dependent on the source of endometrial cells. Fertil Steril. 2005;84(1):16–21.

    Article  PubMed  Google Scholar 

  51. Exacoustos C, Zupi E, Amadio A, et al. Recurrence of endometriomas after laparoscopic removal: sonographic and clinical follow-up and indication for second surgery. J Minim Lnvasive Gynecol. 2006;13(4):281–288.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jun Lin MD.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lin, K., Ma, J., Wu, R. et al. Influence of Ovarian Endometrioma on Expression of Steroid Receptor RNA Activator, Estrogen Receptors, Vascular Endothelial Growth Factor, and Thrombospondin 1 in the Surrounding Ovarian Tissues. Reprod. Sci. 21, 183–189 (2014). https://doi.org/10.1177/1933719113492205

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/1933719113492205

Keywords

Navigation